Anteo Diagnostics to Acquire DIAsource ImmunoAssays
Australia-based Anteo Diagnostics has announced that it will acquire DIAsource ImmunoAssays, a Belgian global specialty diagnostics company, for around $17.3 million.
DIAsource is a provider of clinical diagnostics products in the fields of endocrinology, specifically bone metabolism, fertility, cardiovascular and oncology.
The transaction will give Anteo access to a large manufacturing capability, which will provide a platform to manufacture products at scale. DIAsource has a fully IVD certified production facility to manufacture its complete catalogue of antibodies, ELISA and RIA assays.
Anteo is a developer of products for the life sciences, in-vitro diagnostics, point of care, medical devices and bioseparations markets. —Michael Cipriano